| View |
|
DRP-15107-04
|
Gliclazide
|
Zeltine-MR
|
60 mg
|
Modified-Release Tablet
|
Blood Glucose Lowering (Sulfonylureas)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 October 2024
|
20 December 2028
|
| View |
|
DRP-15337-01
|
Iron + Folic Acid (Vitamin B9)
|
Hemamed Plus
|
300 mg/250 mg
|
Film-Coated Tablet
|
Mineral/Vitamin
|
Flourish Pharma
|
India
|
CLIDP Conversion
|
12 October 2024
|
25 June 2029
|
| View |
|
DRP-15488-01
|
Erythromycin
|
Eryzin
|
5 mg / g (0.5 % w/w)
|
Ophthalmic Ointment
|
Anti-infective
|
Cisen Pharmaceuticals Co., Ltd.
|
China
|
CLIDP Conversion
|
07 October 2024
|
13 November 2028
|
| View |
|
DRP-15663-03
|
Losartan Potassium
|
Rapzar
|
100 mg
|
Film-Coated Tablet
|
Angiotensin ll Receptor Blocker (ARB)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
10 October 2024
|
16 August 2029
|
| View |
|
DRP-15306-01
|
Iron + Folic Acid (Vitamin B9)
|
Vexiron FA
|
190 mg/400 mcg
|
Film-Coated Table
|
Mineral/Vitamin
|
Flourish Pharma
|
India
|
CLIDP Conversion
|
07 October 2024
|
13 June 2029
|
| View |
|
DRP-15338-01
|
Diosmin + Hesperidin
|
Dafcare
|
450 mg/50 mg
|
Film-Coated Tablet
|
Vasoprotective (Capillary Stabilizing Agent)
|
Flourish Pharma
|
India
|
CLIDP Conversion
|
12 October 2024
|
25 June 2029
|
| View |
|
DRP-15113-01
|
Co-Amoxiclav
|
Bactiv
|
457 mg/ 5 mL
|
Powder for Oral Suspension
|
Antibacterial (Combination of Penicillin and Beta Lactamase Inhibitor)
|
Sandoz GmbH
|
Austria
|
CLIDP Conversion
|
07 October 2024
|
02 May 2029
|
| View |
|
DRP-15339-01
|
Diosmin + Hesperidin
|
Dafcare Plus
|
900 mg/100 mg
|
Film-Coated Tablet
|
Vasoprotective (Capillary Stabilizing Agent)
|
Flourish Pharma
|
India
|
CLIDP Conversion
|
12 October 2024
|
25 June 2029
|
| View |
|
DRP-15459-01
|
Clindamycin (as Hydrochloride)
|
Macrodal 300
|
300 mg
|
Capsule
|
Antibacterial (Lincosamide)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
10 October 2024
|
11 September 2027
|
| View |
|
DRP-15347-03
|
Silver Sulfadiazine
|
Blazine
|
10 mg/g (1% w/w)
|
Topical Cream
|
Chemotherapeutic for Topical Use (Sulfonamide)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 October 2024
|
26 June 2029
|
| View |
|
DRP-15347-02
|
Silver Sulfadiazine
|
Fyrazine
|
10 mg/g (1% w/w)
|
Topical Cream
|
Chemotherapeutic for Topical Use (Sulfonamide)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
07 October 2024
|
26 June 2029
|
| View |
|
DRP-4362-01
|
Diclofenac diethylamine
|
Diclojack Gel
|
11.6 mg/g (equivalent to Diclofenac Sodium 10 mg/g (1% w/w)
|
Gel
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Agio Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
10 October 2024
|
08 April 2028
|
| View |
|
DRP-5299-01
|
Allopurinol
|
None
|
300 mg
|
Tablet
|
Antigout
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
CLIDP Conversion
|
07 October 2024
|
10 February 2028
|
| View |
|
DRP-4029-10
|
Cefixime (as Trihydrate)
|
Cefifer-100
|
100 mg/ 5 mL
|
Granules for Suspension (Strawberry Flavor)
|
Antibacterial
|
Pharmevo (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
10 October 2024
|
12 December 2026
|
| View |
|
DRP-4936-03
|
Ketorolac Trometamol
|
Ketovex
|
30 mg / mL
|
Solution for Injection IM/IV
|
Non-Opioid Analgesic
|
Nitin Lifesciences Ltd.
|
India
|
CLIDP Conversion
|
10 October 2024
|
19 November 2028
|
| View |
|
DRP-5040-06
|
Losartan Potassium
|
None
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 October 2024
|
07 January 2029
|
| View |
|
DRP-2371-02
|
Gatifloxacin
|
None
|
3 mg/ mL
|
Ophthalmic Solution
|
Antibacterial (Fluoroquinolone)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
09 October 2024
|
03 August 2030
|
| View |
|
DRP-2748-01
|
Pioglitazone (as hydrochloride)
|
Maedglitazon
|
30 mg
|
Tablet
|
Oral Hypoglycemic
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility)
|
India
|
CLIDP Conversion
|
12 October 2024
|
31 January 2029
|
| View |
|
DRP-2748-02
|
Pioglitazone (as hydrochloride)
|
None
|
30 mg
|
Tablet
|
Oral Hypoglycemic
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility)
|
India
|
CLIDP Conversion
|
12 October 2024
|
31 January 2029
|
| View |
|
DRP-3175-08
|
Atorvastatin (as calcium)
|
VASTATOR
|
40 mg
|
Film-coated Tablet
|
Antihyperlipidemic
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
13 October 2024
|
04 January 2030
|